The IPO Market's Verdict: What Oura's Triumph and Holtec's Retreat Tell Investors

There is a number that Wall Street has been sitting with since Thursday afternoon: 4. That is how many times oversubscribed Oura's initial public offering became in the final days of its roadshow, according to Bloomberg. The smart ring maker is expected to price its 50 million shares at $40 to $44 each this week, raising up to $2.2 billion and debuting on the Nasdaq under the ticker OURA. In the same week, Holtec Nuclear pulled a $900 million IPO the night before pricing. Bamboo Insurance, a CVC-backed homeowners insurer, yanked a $700 million deal citing market conditions. SoftBank's SB Energy delayed a listing that had targeted a valuation above $50 billion. Anthropic, the AI lab that was supposed to be the defining IPO of the fall, quietly shifted its roadshow from October to November.

The same market. The same week. Radically different outcomes. That divergence is not noise. It is a signal about what public investors are actually willing to pay for right now - and what they are not.

The Deals That Died

Holtec Nuclear had planned to sell 50 million shares at $15 to $18, targeting proceeds of up to $900 million. It pulled the deal the night before pricing. The context matters: Standard Nuclear, which listed in July, was trading 20.6% below its offer price at the time of Holtec's withdrawal. X-Energy, public since April, was down 36.7% from its IPO price. The nuclear power sector has been one of the most aggressively marketed investment themes of 2026, tied to the AI data center power buildout. But the public market's verdict on the first wave of nuclear listings was unambiguous, and Holtec's bankers read it correctly.

Bamboo Insurance's situation was structurally similar. The company had planned to sell 35 million shares at $18 to $20, raising up to $700 million for existing shareholders - not for the company itself. Every dollar of proceeds was going to CVC and other insiders. In a market where the 10-year Treasury yield closed above 5% and the 30-year hit its highest level since 2004, asking public investors to pay a premium for a deal that enriches private equity while leaving the company with no new capital is a difficult pitch. The market declined.

SB Energy's delay is the most consequential of the three. SoftBank's data center and power developer had been targeting a valuation above $50 billion. Investors questioned that number. Nvidia agreed to buy an additional $1.5 billion of SB Energy shares ahead of the offering at 90% of the eventual IPO price - a move that signals both Nvidia's strategic interest in the power buildout and the difficulty of clearing a $50 billion valuation in the current rate environment. The deal is delayed, not dead. But the message from institutional investors was clear: the AI infrastructure premium has limits.

The Deal That Flew

Oura is a different kind of company. It makes a wearable health monitor - a ring that tracks sleep, heart rate, and activity - and it is profitable. The company reported $61 million of net income on $1.2 billion of revenue for the first nine months of its fiscal year. It has a subscription model, a loyal user base, and a product that sits at the intersection of consumer health and wearable technology. Its IPO is four times oversubscribed. Banks expect to close the order book Monday afternoon.

The contrast with the pulled deals is instructive. Oura is not asking investors to underwrite a capital-intensive buildout that will take years to generate returns. It is not a nuclear plant under construction or a data center campus that needs a natural gas pipeline. It is a profitable business with recurring revenue, selling shares in a market where the cost of capital is high and patience for speculative cash flows is low. That combination - profitability, recurring revenue, consumer brand - is exactly what institutional investors are willing to pay for when the 10-year yield is at 5.17%.

What Anthropic's Delay Actually Means

Anthropic's decision to move its roadshow from October to November is worth reading carefully. The Wall Street Journal reported that some advisers wanted the extra month so investors could see third-quarter results before committing capital. That is a rational explanation. But the timing also reflects a broader reality: the AI safety debate that intensified in September - rogue agents, public calls to slow development, the OpenAI IPO delay - has introduced a new variable into the valuation conversation that bankers need time to work through.

Anthropic's annualized revenue is expected to exceed $100 billion this year, up roughly 50% from two months earlier. The company told shareholders to expect a second consecutive quarter of adjusted operating profit. The business is strong. The question is not whether Anthropic can go public - it is what multiple public investors will assign to a frontier AI lab in a market where the 10-year yield is at 5.17%, nuclear IPOs are being pulled, and the AI safety debate is actively reshaping the regulatory landscape. November gives the company one more quarter of data to answer that question.

What Investors Should Watch

The IPO market in late September 2026 is not broken. It is discriminating. Profitable companies with recurring revenue and clear business models are clearing the market at strong valuations. Capital-intensive infrastructure plays with long payback periods and speculative cash flows are not. That bifurcation is not a temporary anomaly - it is the logical consequence of a rate environment where every dollar of future earnings is being discounted more aggressively than it was two years ago.

For investors, the lesson is straightforward. The deals that are getting done tell you what the market values: profitability, capital efficiency, and near-term cash generation. The deals that are being pulled tell you what the market is skeptical of: leverage, long construction timelines, and valuations that require a decade of flawless execution to justify. Oura's four-times oversubscription and Holtec's withdrawal are two sides of the same coin. The IPO market is not closed. It is just asking harder questions than it was six months ago.